Antimicrobial resistance of helicobacter pylori clinical strains in the last 10 years

Polish Journal of Microbiology

Volumn 58, Issue 4, 2009, Pages 301-305

  Andrzejewska, Ewa ^a   Szkaradkiewicz, Andrzej ^a   Karpinsk, Tomasz ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Clinical isolates; Drug resistance; Helicobacter pylori

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOPSY; DRUG SENSITIVITY; EPSILOMETER TEST; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

DRUG RESISTANCE, MULTIPLE, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; POLAND; TIME FACTORS;

HELICOBACTER PYLORI;

EID: 77649194281     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Andrzejewska E. and H. Klincewicz. 1995. In vitro susceptibility of Helicobacter pylori strains to several antimicrobial agents. Gastroenterol. Pol. 2: 309-313.
2. Borysiewicz J., A. Bolek, B. Prażmowska, J. Komorowski and M. Mikolajska. 1993. Drug resistance of Helicobacter pylori strains isolated from patient with inflammation of stomach mucous membrane and peptic ulcer of stomach and duodenum (in Polish). Med. Dośw. Mikrobiol. 45: 339-343.
3. Cameron E.A.B., K. Powell, L. Baldwin, P. Jones, G.D. Bell and S.G.J. Williams. 2004. H. pylori resistance and eradication rates in Suffolk, UK, 1991-2001. J. Med. Microbiol. 53: 535-538.
4. Chisholm S.A., E.L. Teare, K. Davies and R.J. Owen. 2007. Surveillance of primary antibiotic resistance of H. pylori at centres in England and Wales over a six year period (2000-2005). Euro Surveill. 12:721.
5. Dzierżanowska-Fangrat K., E. Rożynek, D. Celińska-Cedro, M. Jarosz, J. Pawlowska, A. Szadkowski, A. Budzyńska, J. Nowak, W. Romańczuk, R. Prosiccki, P. Jóżwiak and D. Dzierżanowska. 2005. Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study. Int. J. Antimicrob. Agents. 26: 230-234.
6. Francesco V., M. Margiotta, A. Zullo and C. Hassan, N.D. Valle, O. Burattini, R. D'Angelo, G. Stoppino, U. Cea, F. Giorgio, R. Monno, S. Morini, C. Panella and E. Ierardi. 2006. Claritromycin resistance and H. pylori genotype in Italy. J. Micro biol. 44: 660-664.
7. Gerrits M.M., A.H.M. van Vliet, E.J. Kuipers, J.G. Kusters. 2006. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet. 6: 699-709.
8. Janssen M.J.R., L. Hendrikse, S.Y. De Boer,. R. Bosboom, W.A. De Boer, R.J.F. Laheij and J.B.M.J. Jansen. 2006. Helicobacter pylori antibiotic resistance in a Dutch region: trends over time. Netherlands J. Med. 64: 191-195.
9. Konturek P.C., J. Kania, J.W. Konturek, A. Nikiforuk, S.J. Konturek and E.G. Hahn. 2003. H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPARg and impaired apoptosis in gastric carcinogenesis. Med. Sci. Monit. 9: SR53-66.
10. Loffeld R.J.L.F. and C.A.P.M.J. Fijen. 2003. Antibiotic resistance of Helicobacter pylori: a cross-sectional study in consecutive patients, and relation to ethnicity. Clin. Microbiol. Infect. 9: 600-604.
11. Lui S.Y., K.G. Yeoh and B. Ho. 2003. Metronidazole - resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population. J. Clin. Microbiol. 14: 5011-5014.
12. Łekowska-Kochaniak A. and J. Popowska. 1999. Antimicrobial resistance of Helicobacter pylori strains isolated from patients. Gastroenterol. Pol. 6: 209-213.
13. Malfertheiner P., F. Mégraud, C. O'Morain, A.P.S. Hungins, R. Jones, A. Axon, D.Y. Graham, G. Tytgat and European Helicobacter Pylori Study Group (EHPSG). 2002. Current concepts in the management of Helicobacter pylori infection - The Maastricht 2-2000 Consensus Report. Aliment. Pharmacol. Ther. 16: 167-180.
14. Masuda H., T. Hiyama. M. Yoshihara, S. Tanaka, K. Haruma and K. Chayama. 2004. Characteristics of trends of clarithromycin-resistant H. pylori isolates in Japan over a decade. Pathobiol. 71: 159-163.
15. McLoughlin R., I. Racz, M. Buckley, H.J.O. O'Connor and C O'Morain. 2004. Therapy of Helicobacter pylori. Helicobacter 9 (Suppl. 1): 42-48.
16. Mégraud F. 2004. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut. 53: 1374-1384.
17. Mégraud F. and H. Lamouliatte. 2003. Review article: the treatment of refractory Helicobacter pylori infection. Aliment. Phar macol. Ther. 17: 1333-1343.
18. Mégraud F. and P. Lehours. 2007. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin. Microbiol. Rev. 20: 280-322.
19. Perez-Perez G.I., D. Rothenbacher and H. Brenner. 2004. Epidemiology of Helicobacter pylori infection. Helicobacter 9 (Suppl. 1): 1-6.
20. Rożynek E., K. Dzierżanowska-Fangrat, D. Celińska-Cedro, P. Jóżwiak, K. Madaliński and D. Dzierżanowska. 2002. Primary resistance of Helicobacter pylori to antimicrobial agents in Polish children. Acta Microbiol. Pol. 51: 255-263.